Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05818969 · ClinicalTrials.gov registry record · NA
Effects of Hypnosis Therapy on Outcomes in Total Knee Replacement
A NA study, sponsored by Foundation for Orthopaedic Research and Education.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
NCT05818969: Completed NA study, sponsored by Foundation for Orthopaedic Research and Education.
NCT05818969 is a NA study that has completed, run by Foundation for Orthopaedic Research and Education. The registered enrollment target is 73 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05818969, a NA study, has completed, sponsored by Foundation for Orthopaedic Research and Education.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
Study Summary
The purpose of this study is to collect information to evaluate the role of the psychogenic component of pain induced by anxiety on postoperative outcomes in major orthopaedic surgery and to determine whether hypnosis therapy provided during the perioperative period will lead to decreased use of opioid therapy. Patients are randomly assigned to one of two treatment groups: (I) usual care, or; (II) hypnotherapy treatment. Patients have an equal chance of being assigned to one of the two groups.
Primary Outcome
Patient-reported anxiety in the perioperative period
Interventions
- BEHAVIORAL Hypnosis Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT05818969 record still lists
NCT05818969 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 73 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Hypnosis Therapy is the first listed.
NCT05818969 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05818969 about?
NCT05818969 is a clinical study titled "Effects of Hypnosis Therapy on Outcomes in Total Knee Replacement". The purpose of this study is to collect information to evaluate the role of the psychogenic component of pain induced by anxiety on postoperative outcomes in major orthopaedic surgery and to determine whether hypnosis therapy provided during the perioperative period will lead to decreased use of opi...
What is the current status of trial NCT05818969?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2022-02-01. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05818969?
The interventions under investigation include: Hypnosis Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05818969?
This trial is sponsored by Foundation for Orthopaedic Research and Education, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05818969's enrollment target sits among peer trials
73 1089th of 2000 higher than 912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03661307 · 73 participants · Phase 1
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- NCT05386108 · 73 participants · Phase 1
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- NCT05961592 · 73 participants · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
- NCT06150664 · 73 participants · Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI